Clene Inc.
For the period ended Aug 10, 2026. Filed Aug 10, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 10, 2026 · Filed Aug 10, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.2 · About CNM-Au8®
About CNM-Au8®
CNM-Au8 is an oral suspension of gold nanocrystals developed to restore neuronal health and function by increasing energy production and utilization. The catalytically active nanocrystals of CNM-Au8 drive critical cellular energy producing reactions that enable neuroprotection and remyelination by increasing neuronal and glial resilience to disease-relevant stressors. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.